YusufS, HawkenS, OunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet2004; 364: 937-52
2.
JacobsenBK, KnutsenSF, FraserGE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist health study. J Clin Epidemiol1999; 52: 303-7
3.
LøkkegaardE, JovanovicZ, HeitmannBL, KeidingN, OttesenB, PedersenAT. The association between early menopause and risk of ischaemic heart disease: influence of hormone therapy. Maturitas2006; 53: 226-33
4.
StevensonJC. Menopausal hormone therapy. In: WengerNK, Collins Peds. Women & Heart Disease.London: Taylor & Francis, 2005: 375-9
RossouwJE, PrenticeRL, MansonJEPostmenopausal hormone therapy and risk of cardiovascular disease by age and time since menopause. JAMA2007; 297: 1465-77
9.
Writing Group for the Women's Health Initiative Investigators.Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA2002; 288: 321-33
10.
CollinsP, FlatherM, LeesB, MisterR, ProudlerAJ, StevensonJC. Randomized trial of effects of continuous combined HRT on markers of lipids and coagulation in women with acute coronary syndromes: WHISP pilot study. Eur Heart J2006; 27: 2046-53
11.
StevensonJCon behalf of the International Consensus Group on HRT and Regulatory Issues. HRT, osteoporosis and regulatory authorities: Quis custodiet ipsos custodes?Hum Reprod2006; 21: 1668-71
